Published in Ophthalmology on June 01, 1999
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18
Age-related macular degeneration. Lancet (2008) 3.34
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Epidemiology of age-related maculopathy: a review. Eur J Epidemiol (2003) 2.32
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol (2010) 1.78
Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology (2009) 1.76
Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet (2014) 1.69
Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Am J Ophthalmol (2011) 1.61
A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet (2003) 1.53
The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest Ophthalmol Vis Sci (2013) 1.46
Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 national health interview survey. Am J Public Health (2008) 1.42
Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol (2001) 1.41
Age-Related Macular Degeneration and Coronary Artery Disease in a VA Population. South Med J (2015) 1.40
Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol (2006) 1.29
Functional rescue of degenerating photoreceptors in mice homozygous for a hypomorphic cGMP phosphodiesterase 6 b allele (Pde6bH620Q). Invest Ophthalmol Vis Sci (2008) 1.22
Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology (2008) 1.22
Vision impairment and eye care utilization among Americans 50 and older. Curr Eye Res (2010) 1.06
Prevalence of early and late age-related macular degeneration in India: the INDEYE study. Invest Ophthalmol Vis Sci (2009) 1.05
Medical record validation of self-reported eye diseases and eye care utilization among older adults. Curr Eye Res (2012) 1.05
Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol (2009) 1.05
The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br J Ophthalmol (2005) 1.03
Progress in defining the molecular biology of age related macular degeneration. Hum Genet (2007) 1.01
Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. Am J Ophthalmol (2010) 0.97
Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab. Eye (Lond) (2012) 0.94
Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant (2011) 0.93
Plasma apolipoproteins and risk for age related maculopathy. Br J Ophthalmol (2006) 0.92
Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol (2008) 0.91
Age-related macular degeneration. J R Soc Med (2009) 0.89
Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Do nutritional supplements have a role in age macular degeneration prevention? J Ophthalmol (2014) 0.87
Sources of binocular suprathreshold visual field loss in a cohort of older women being followed for risk of falls (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2007) 0.87
Therapeutic margins in a novel preclinical model of retinitis pigmentosa. J Neurosci (2013) 0.87
Race, iris color, and age-related macular degeneration. Trans Am Ophthalmol Soc (2000) 0.86
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration. Drug Des Devel Ther (2013) 0.86
An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism. Invest Ophthalmol Vis Sci (2009) 0.85
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration. Biochem Med (Zagreb) (2012) 0.85
The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. Am J Ophthalmol (2009) 0.84
Role of statins in the development and progression of age-related macular degeneration. Retina (2013) 0.82
Estimated prevalence and risk factor for age-related maculopathy. Yonsei Med J (2008) 0.81
Level of education associated with ophthalmic diseases. The Beijing Eye Study. Graefes Arch Clin Exp Ophthalmol (2009) 0.81
Dietary and lifestyle risk factors associated with age-related macular degeneration: a hospital based study. Indian J Ophthalmol (2013) 0.80
Zinc uptake and storage: the role of fundus pigmentation. Graefes Arch Clin Exp Ophthalmol (2005) 0.79
The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration. Nutrients (2016) 0.77
Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy. Expert Rev Ophthalmol (2013) 0.77
Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis. Ophthalmology (2016) 0.77
HLA class II genotypes are not associated with age related macular degeneration in a case-control, population-based study. Hum Immunol (2015) 0.75
Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration. Ophthalmology (2017) 0.75
Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach. Med Hypothesis Discov Innov Ophthalmol (2015) 0.75
Population-based age group specific annual incidence rates of symptomatic age-related macular degeneration. Open Ophthalmol J (2014) 0.75
[Age-related macular degeneration and risk of stroke]. J Fr Ophtalmol (2008) 0.75
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial. Trials (2016) 0.75
Differences of frequency in administration of ranibizumab and bevacizumab in patients with neovascular AMD. Wien Klin Wochenschr (2014) 0.75
Simultaneous dexamethasone intravitreal implant and anti-VEGF therapy for neovascular age-related macular degeneration resistant to anti-VEGF monotherapy. J Vitreoretin Dis (2017) 0.75
The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 10.88
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
The Wisconsin age-related maculopathy grading system. Ophthalmology (1991) 7.62
The Beaver Dam Eye Study: visual acuity. Ophthalmology (1991) 6.87
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 6.47
Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol (1998) 6.04
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91
Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep (1997) 5.66
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Comparison of self-reported and measured height and weight. Am J Epidemiol (1982) 4.92
Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA (2000) 4.86
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med (1997) 4.35
Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA (1988) 4.31
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology (1998) 4.21
The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08
Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol (2000) 3.94
Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA (1998) 3.86
The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes (1984) 3.66
Visual impairment in diabetes. Ophthalmology (1984) 3.64
The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1993) 3.58
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol (1994) 3.24
Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology (1985) 3.20
The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2000) 3.17
An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05
The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci (1995) 2.99
Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology (1996) 2.98
Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91
Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89
Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc (1998) 2.88
Sleep apnea and hypertension. A population-based study. Ann Intern Med (1994) 2.79
Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study. Ophthalmology (2001) 2.71
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology (1995) 2.70
The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology (1992) 2.70
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1989) 2.59
Reflections on sex-related risk of eye disease. Arch Ophthalmol (2001) 2.54
Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology (1989) 2.51
Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology (1998) 2.50
Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep (1997) 2.48
Association of NIDDM and hearing loss. Diabetes Care (1998) 2.45
Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol (1994) 2.39
The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol (1993) 2.37
Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1994) 2.36
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA (1999) 2.35
The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (1999) 2.33
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol (1989) 2.31
The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol (1991) 2.14
Dietary fat and age-related maculopathy. Arch Ophthalmol (1995) 2.11
A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr (1993) 2.06
Diabetic retinopathy. Assessment of severity and progression. Ophthalmology (1984) 2.05
The gender bias in sleep apnea diagnosis. Are women missed because they have different symptoms? Arch Intern Med (1996) 2.04
Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol (1984) 2.04
The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol (1998) 1.93
Epidemiology of proliferative diabetic retinopathy. Diabetes Care (1992) 1.91
Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol (1994) 1.91
Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology (1995) 1.86
The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med (2000) 1.86
Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol (1993) 1.81
Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol (2000) 1.79
Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med (1994) 1.78
Accuracy of self-reported hearing loss. Audiology (1998) 1.77
Sleep-disordered breathing and neuropsychological deficits. A population-based study. Am J Respir Crit Care Med (1997) 1.77
Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology (1994) 1.74
Diet and nuclear lens opacities. Am J Epidemiol (1995) 1.73
Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol (1999) 1.73
Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative. Neurology (2012) 1.68
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol (1998) 1.65
How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol (2001) 1.65
Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr (1998) 1.62
Cataracts and macular degeneration in older Americans. Arch Ophthalmol (1982) 1.61
Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health (1992) 1.61
Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med (1994) 1.59
Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol (1999) 1.59